Figure 1From: Designing a HER2/neupromoter to drive α1,3galactosyltransferase expression for targeted anti-αGal antibody-mediated tumor cell killingExpression of the c-erbB-2 gene in various cell lines. Total RNAs from HEK-293 and human breast cancer cell lines MCF-7, SK-BR-3, MDA-MB-231 and MDA-MB-453 were probed with c-erbB-2 cDNA and thereafter with glyceraldehyde 3-phosphate-dehydrogenase (GAPDH) cDNA as a control.Back to article page